British CDMO Oxford Biomedica plc announces the expansion of its License and Supply Agreement with cell therapy specialist Cabaletta Bio, Inc. The new agreements adds CD19 as a new target – it originally covered Cabaletta Bio’s lead product, DSG3-CAART.
UK invests in biopharma manufacturers
Latest NewsThe UK is making €15m investment in its biopharmaceutical manufacturing industry via its national innovation agency Innovate UK. It is part of the country’s larger push to support the domestic Life Sciences.
Synbio experts develop cells that hear
Latest NewsETH Zurich researchers have developed a gene switch that triggers insulin release in designer cells by playing music.
Oxford Biomedica expands agreement with Cabaletta Bio
Latest NewsBritish CDMO Oxford Biomedica plc announces the expansion of its License and Supply Agreement with cell therapy specialist Cabaletta Bio, Inc. The new agreements adds CD19 as a new target – it originally covered Cabaletta Bio’s lead product, DSG3-CAART.
Researchers decipher mystery of oil-eating microbes
Latest NewsOil-eating bacteria form dendritic biofilms that reshape oil droplets to speed up the rate of consumption
Valneva announces extension of existing loan agreement
Latest NewsFrench vaccine maker Valneva SE will double the amount of a US$100m debt financing granted by Deerfield Management Company and OrbiMed.
Celonic Group with new CEO
AppointmentsBasel- and Heidelberg-based CDMO Celonic Group has appointed Dr Samanta Cimitan as Chief Executive Officer (CEO).
Spexis AG bags money for pivotal Phase III trial
Latest NewsSwiss Spexis AG has announced a US$2.5m capital commitment to fund a two-part pivotal Phase III study to get market approval for its inhaled cystic fibrosis antibiotic colistimethate sodium.
Novo Nordisk takes over Inversago Pharma Inc.
Latest NewsWith a US$1bn acquisition of Canadian Inversago Pharma, Novo Nordisk A/S fiights to maintain its dominant position in the booming weight loss drug market.
Promising viral gene therapy for genetic kidney disease
Latest NewsBritish researchers have proven that a new gene can prevent progression of hereditary kidney damage in mice.
Alianza Team invests in microbial oil maker Clean Food Group
Latest NewsLipid, nutrition and frozen bakery specialist Allianza Team puts £900,500 into pre-Series A financing of microbial palm oil producer Clean Food Group Ltd.